COGNITION THERAPEUTICS INC

CGTX

COGNITION THERAPEUTICS INC

CGTX

Insider Sentiment (TTM):

Last Purchase:2026-04-16Last Sale:-Shares Purchased (TTM):29,175Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:21,192,255Shares Outstanding:89,191,313Institutional Ownership Pct.:23.76%

Earnings Market Reaction:

Filing Date:2026-08-07Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	34	31	37	39	11	16	25	22	29	35	30	33
Grants Receivable Current	3	4	10	2	6	5	3	3	3	1	1	2
Prepaid Expense Current	1	1	1	1	1	2	2	1	2	2	3	1
Restricted Cash Equivalents Current	1	0	0	0	1	-	-	-	-	-	-	-
Assets Current	38	36	48	43	19	23	30	27	34	38	34	36
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Right Of Use Asset	1	0	0	0	0	0	0	1	1	1	1	1
Other Assets	-	-	-	-	-	-	-	-	-	-	-	2
Assets	39	36	48	43	20	24	30	28	34	39	35	39
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	1	4	1	1	1	2	2	2	3	3	4	3
Accrued Liabilities Current	4	2	12	4	9	8	8	10	6	5	4	4
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Other Liabilities Current	0	0	0	-	0	0	0	-	0	0	1	0
Liabilities Current	5	6	14	7	12	11	11	13	11	10	10	8
Operating Lease Liability Noncurrent	0	0	0	0	0	0	0	0	0	0	1	1
Other Liabilities Noncurrent	-	-	-	-	-	-	-	-	-	0	0	1
Liabilities	6	6	14	7	13	11	11	13	11	10	11	10
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	240	233	233	232	197	196	194	182	180	179	166	162
Retained Earnings Accumulated Deficit	-207	-203	-199	-195	-190	-184	-175	-167	-157	-150	-141	-133
Accumulated Other Comprehensive Income Loss Net Of…	-	-	-	-	-	-	-	-	-	-	-0	-0
Stockholders Equity	33	30	34	37	7	12	19	14	23	29	24	29
Liabilities And Stockholders Equity	39	36	48	43	20	24	30	28	34	39	35	39
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	250	250	250	250	250	250	250	250	250	250	250	250
Common Stock Shares Issued	95	89	89	88	65	62	60	41	40	40	32	30
Shares Outstanding	95	89	89	88	65	62	60	41	40	40	32	30

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-2.48%	-7.44%	-23.97%	-	-	-	-	-	-	-	-	-
2025	-32.68%	-15.49%	136.62%	258.94%	96.45%	155.54%	4.82%	-12.65%	-13.86%	10.19%	5.56%	12.04%
2024	1.56%	-13.54%	23.44%	21.54%	-28.03%	-3.42%	-21.04%	40.60%	34.64%	-17.33%	-29.51%	-30.91%
2023	-	-	-	-9.30%	-16.28%	-33.72%	-0.98%	66.67%	125.49%	0.55%	7.10%	18.58%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	7.03	5.92	3.45	6.44	1.54	2.09	2.65	2.11	3.07	4.00	3.37	4.38
Quick Ratio	6.92	5.76	3.37	6.27	1.44	1.94	2.49	2.00	2.90	3.74	3.07	4.21
Working Capital	32.85M	29.76M	34.07M	36.23M	6.69M	11.92M	18.41M	14.13M	22.63M	28.47M	24.05M	27.81M
Leverage & Debt
Debt to Equity	0.18	0.21	0.41	0.19	1.79	0.92	0.61	0.90	0.49	0.35	0.44	0.34
Interest Coverage TTM	-1,742.90	-2,040.05	-2,276.14	-1,180.29	-1,604.21	-1,449.70	-1,284.90	-1,498.26	-1,545.11	-1,509.54	-1,370.92	-1,601.25
Debt Ratio	0.15	0.17	0.29	0.16	0.64	0.48	0.38	0.47	0.33	0.26	0.30	0.25
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-0.19	-0.22	-0.32	-0.36	-0.52	-0.54	-0.86	-0.85	-0.78	-0.85	-0.86	-0.75
Free Cash Flow Per Share TTM	-0.24	-0.23	-0.34	-0.25	-0.33	-0.50	-0.72	-0.63	-0.57	-0.61	-0.54	-0.69
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	-49.16%	-41.21%	-30.86%	-18.34%	6.15%	15.76%	31.73%	50.12%	36.89%	21.22%	20.52%	-8.03%
EPS Growth (1Y)	-64.27%	-59.25%	-62.25%	-57.66%	-33.23%	-36.84%	-0.43%	12.78%	1.19%	4.55%	-5.12%	-30.26%
Valuation Metrics
P/E TTM	-6.21	-3.46	-4.18	-3.76	-0.60	-0.78	-0.82	-0.55	-2.14	-2.13	-2.15	-1.92
P/B TTM	3.16	2.27	2.87	2.88	2.81	2.12	1.49	1.31	2.89	2.13	2.27	1.51
Market Cap	104.22M	67.79M	98.24M	105.23M	19.74M	26.03M	27.85M	18.96M	66.50M	61.40M	55.55M	43.73M
Enterprise Value	69.46M	36.56M	61.24M	65.41M	8.19M	9.60M	2.84M	-3.05M	37.97M	26.73M	25.63M	10.76M
Calculated Values
Free Cash Flow TTM	-22.02M	-20.25M	-24.59M	-19.66M	-20.86M	-31.11M	-28.48M	-25.58M	-22.95M	-20.70M	-16.21M	-20.91M
Net Debt	-34.76M	-31.23M	-37.00M	-39.82M	-11.56M	-16.43M	-25.01M	-22.01M	-28.53M	-34.67M	-29.92M	-32.97M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-04-16Purchase

Owner: Caggiano, Anthony

Title: Chief Medical Officer

Shares: 10,000

Price/Share: $1.11

Value: $11,100.00

Shares Owned: 874,906

Relationship: Officer

Ownership: Direct

2026-04-16Purchase

Owner: Ricciardi, Lisa

Title: CEO & President

Shares: 9,175

Price/Share: $1.10

Value: $10,092.50

Shares Owned: 1,715,851

Relationship: Director,Officer

Ownership: Direct

2026-04-16Purchase

Owner: Doyle, John Brendan

Title: Chief Financial Officer

Shares: 10,000

Price/Share: $1.13

Value: $11,300.00

Shares Owned: 627,509

Relationship: Officer

Ownership: Direct

2025-01-31Purchase

Owner: Ricciardi, Lisa

Title: CEO & President

Shares: 38,851

Price/Share: $0.77

Value: $29,915.27

Shares Owned: 38,851

Relationship: Director,Officer

Ownership: Indirect

2024-03-14Purchase

Owner: Ricciardi, Lisa

Title: CEO & President

Shares: 5,700

Price/Share: $1.75

Value: $9,975.00

Shares Owned: 291,345

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-04-16	Caggiano, Anthony	Officer	Chief Medical Officer	Direct	Purchase	10,000	1.11	$11,100.00	874,906	4
2026-04-16	Ricciardi, Lisa	Director,Officer	CEO & President	Direct	Purchase	9,175	1.10	$10,092.50	1,715,851	4
2026-04-16	Doyle, John Brendan	Officer	Chief Financial Officer	Direct	Purchase	10,000	1.13	$11,300.00	627,509	4
2025-01-31	Ricciardi, Lisa	Director,Officer	CEO & President	Indirect	Purchase	38,851	0.77	$29,915.27	38,851	4
2024-03-14	Ricciardi, Lisa	Director,Officer	CEO & President	Direct	Purchase	5,700	1.75	$9,975.00	291,345	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

23.76%

Inst. Shares: 21,192,255

Shares Outstanding: 89,191,313

2025-12-31

32.16%

Inst. Shares: 23,405,065

Shares Outstanding: 72,766,983

2025-09-30

27.21%

Inst. Shares: 21,207,978

Shares Outstanding: 77,951,513

2025-06-30

16.53%

Inst. Shares: 10,526,480

Shares Outstanding: 63,690,945

2025-03-31

17.02%

Inst. Shares: 10,520,177

Shares Outstanding: 61,828,149

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	21,192,255	89,191,313	23.76%
2025-12-31	23,405,065	72,766,983	32.16%
2025-09-30	21,207,978	77,951,513	27.21%
2025-06-30	10,526,480	63,690,945	16.53%
2025-03-31	10,520,177	61,828,149	17.02%
2024-12-31	10,706,152	39,730,148	26.95%
2024-09-30	3,746,847	40,418,065	9.27%
2024-06-30	5,014,984	40,062,954	12.52%
2024-03-31	6,553,381	33,735,269	19.43%
2023-12-31	6,795,809	30,029,087	22.63%
2023-09-30	6,882,196	30,365,506	22.66%
2023-06-30	6,786,999	29,614,822	22.92%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

COGNITION THERAPEUTICS INC (CGTX) — SEC Financial Statements & Analysis

COGNITION THERAPEUTICS INC (CGTX) is a biological products, (no diagnostic substances) company, incorporated in DE. COGNITION THERAPEUTICS INC trades on Nasdaq as: CGTX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), COGNITION THERAPEUTICS INC reported a Debt-to-Equity ratio of 0.18x, a Price-to-Book (P/B) ratio of 3.16x (TTM), at a market cap of $104.22M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.18x
P/B TTM: 3.16x
Market Cap: $104.22M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is COGNITION THERAPEUTICS INC in?

COGNITION THERAPEUTICS INC (CGTX) operates in the Biological Products, (No Diagnostic Substances) industry.

What is CGTX's market cap?

COGNITION THERAPEUTICS INC (CGTX) has a market capitalization of $104.22M as of 2026-06-30.

What exchange does CGTX trade on?

COGNITION THERAPEUTICS INC (CGTX) trades on the Nasdaq.

Where is COGNITION THERAPEUTICS INC incorporated?

COGNITION THERAPEUTICS INC is incorporated in DE.